How healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s digital transformation of society has dramatically accelerated this.<
The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape - and one of the key ones is digital transformation
With recent market changes catalysing a rapid shift to an omnichannel approach, life science organisations of every size are racing to adapt their commercial approach to be more relevant, c
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
